Zinc oxide is the most zinc-dense form (~80% elemental zinc) but the poorest-absorbed of the common oral salts when taken fasting. Its main real-world roles are topical (sunscreens, diaper/barrier creams) and as the high-dose zinc source in the AREDS eye-health formula — not everyday oral supplementation. For zinc’s full evidence base see Zinc; this page covers what’s specific to the oxide form.
Absorption & Tolerability
Zinc oxide is the most zinc-dense oral form — molar mass makes it about 80% elemental zinc by weight — but it is also the least water-soluble of the common salts, and that is the crux of its reputation as “poorly absorbed.” The reality is context-dependent:
- As a fasting supplement, oxide absorbs less than the soluble salts. In a stable-isotope crossover in 15 healthy adults, fractional zinc absorption from zinc citrate (~61%) and gluconate (~61%) was significantly higher than from zinc oxide (~50%) when each was given as a 10 mg dose without food 1Reference 1RCTZinc absorption by young adults from supplemental zinc citrate is comparable with that from zinc gluconate and higher than from zinc oxide — randomized crossover stable-isotope studyView study →. A 2024 narrative review of the human comparative-absorption literature reaches the same conclusion: the water-soluble forms are the more reliable choice for oral repletion, and oxide is the weak link 2Reference 2ReviewNutrients. https://pubmed.ncbi.nlm.nih.gov/39770891/View study →.
- In an acidic food matrix, the gap can disappear. When zinc oxide was added as a fortificant to maize/corn tortillas and measured by dual-isotope tracer, fractional absorption did not differ from zinc sulfate 3,4Reference 3Zinc absorption from zinc oxide, zinc sulfate, zinc oxide + EDTA, or sodium-zinc EDTA does not differ when added as fortificants to maize tortillas — stable-isotope studyView study →Reference 4RCTBioavailability of zinc oxide added to corn tortilla is similar to that of zinc sulfate and is not affected by simultaneous addition of iron (2012) — randomized crossover isotope study. Food and Nutrition Bulletin. https://pubmed.ncbi.nlm.nih.gov/23424892/View study →. Gastric acid dissolves the oxide during digestion, so the “insoluble = unabsorbable” shorthand is too strong once stomach acid and a food meal are involved. (In an achlorhydric or acid-suppressed gut, that advantage is lost — a real-world caveat for older or PPI-treated users.)
Practical read: the one place a clear form-based recommendation holds is oral repletion where absorption matters — prefer a soluble form (citrate, gluconate, bisglycinate) over oxide 1,2Reference 1RCTZinc absorption by young adults from supplemental zinc citrate is comparable with that from zinc gluconate and higher than from zinc oxide — randomized crossover stable-isotope studyView study →Reference 2ReviewNutrients. https://pubmed.ncbi.nlm.nih.gov/39770891/View study →. Oxide’s staying power is economic: it is cheap and zinc-dense, which is why it fills low-cost multivitamins and the high-dose AREDS formula. Gastrointestinally, all oral zinc salts can cause nausea on an empty stomach; oxide is not distinctively better or worse tolerated at matched elemental doses. Topically, zinc oxide is inert and very well tolerated, forming a physical barrier rather than being absorbed 5,6Reference 5Characterization of the UVA protection provided by avobenzone, zinc oxide, and titanium dioxide in broad-spectrum sunscreen productsView study →Reference 6Microfine zinc oxide (Z-cote) as a photostable UVA/UVB sunblock agent — comparative studyView study →.
What the Evidence Says
The evidence specific to the oxide form clusters in three non-supplement roles. For zinc’s systemic evidence base (immune function, the common cold, deficiency and repletion), see the Zinc hub — those trials are not form-specific and are not repeated here.
1. High-dose eye health (AREDS). The Age-Related Eye Disease Study used zinc oxide, 80 mg/day elemental, with 2 mg copper, and the original trial found the antioxidant-plus-zinc formulation reduced the ~5-year risk of progression to advanced age-related macular degeneration (AMD) in people at intermediate-to-high risk 7Reference 7RCTA randomized, placebo-controlled clinical trial of high-dose vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss — AREDS report noView study →. AREDS2 refined the formula (adding lutein/zeaxanthin, dropping beta-carotene) and, in its dose sub-question, found lowering zinc from 80 mg to 25 mg did not significantly change the benefit — i.e., the 80 mg oxide dose is not clearly necessary 8Reference 8RCTLutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration — the AREDS2 randomized clinical trial (includes the 80 mg vs 25 mg zinc sub-randomization)View study →. A 2023 Cochrane review rates the AMD-progression benefit of the antioxidant/mineral formula as moderate-certainty evidence, applicable to people who already have AMD, not to prevention in healthy eyes 9Reference 9Systematic reviewAntioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration — systematic reviewView study →. The 80 mg dose is twice the adult UL and is an AMD-treatment decision made with a clinician — not a self-selected general supplement.
2. Sunscreen / photoprotection. Zinc oxide is one of only two US-approved actives (with avobenzone) that give true broad-spectrum UVA protection out past 360 nm 5Reference 5Characterization of the UVA protection provided by avobenzone, zinc oxide, and titanium dioxide in broad-spectrum sunscreen productsView study →, and microfine (“Z-cote”) grades are photostable UVA/UVB blockers that stay transparent on skin 6Reference 6Microfine zinc oxide (Z-cote) as a photostable UVA/UVB sunblock agent — comparative studyView study →. Multiple reviews and human in-vivo studies find that even nanoparticle zinc oxide does not meaningfully penetrate past the outer stratum corneum — including under occlusion or on barrier-impaired skin — so systemic uptake from sunscreen is negligible 10,11Reference 10ReviewThe safety of nanosized particles in titanium dioxide- and zinc oxide-based sunscreens — reviewView study →Reference 11Human skin penetration and local effects of topical nano zinc oxide after occlusion and barrier impairment — human in-vivo validation studyView study →.
3. Topical barrier and wound care. Zinc oxide paste is a long-standing barrier treatment for diaper dermatitis; small randomized trials support zinc oxide preparations against irritant diaper rash 12Reference 12RCTEfficacy of topical application of eosin compared with zinc oxide paste and corticosteroid cream for diaper dermatitis (1999) — randomized controlled trial. Dermatology. https://pubmed.ncbi.nlm.nih.gov/10640841/View study →, and zinc-oxide/petrolatum barrier formulations improve skin condition versus no barrier 13Reference 13RCTSkin benefits from continuous topical administration of a zinc oxide/petrolatum formulation by a novel disposable diaper (2001) — randomized controlled trial. JEADV. https://pubmed.ncbi.nlm.nih.gov/11720074/View study →. Zinc’s role in the biochemistry of wound repair (as a cofactor for matrix metalloproteinases and keratinocyte migration) is well described 14Reference 14ReviewZinc in wound healing: theoretical, experimental, and clinical aspects — reviewView study →, though most topical zinc-oxide wound and leg-ulcer use rests on tradition and small studies rather than large modern RCTs.
Bottom line for the form: zinc oxide’s evidence is strongest where it is not absorbed — on the skin (sunscreen, barrier creams) and as the cheap high-dose zinc in AREDS. For everyday oral zinc, a soluble form is the better-absorbed choice.
Dosage
Dosed as elemental zinc; because oxide is ~80% zinc by weight, ~100 mg of zinc oxide supplies ~80 mg elemental zinc. See the Zinc hub for intake references (RDA 8–11 mg/day; UL 40 mg/day for adults, counting supplements, not food).
- Oral repletion: if using zinc at all for repletion, a soluble form is preferred 1,2Reference 1RCTZinc absorption by young adults from supplemental zinc citrate is comparable with that from zinc gluconate and higher than from zinc oxide — randomized crossover stable-isotope studyView study →Reference 2ReviewNutrients. https://pubmed.ncbi.nlm.nih.gov/39770891/View study →; where oxide is used (multivitamins), take with an acidic meal to aid dissolution and split larger doses (fractional absorption falls as the single dose rises).
- AREDS eye formula: 80 mg/day elemental zinc (as oxide) with 2 mg copper — 2× the UL, used under medical supervision for existing AMD, not a dose to self-select 7,8Reference 7RCTA randomized, placebo-controlled clinical trial of high-dose vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss — AREDS report noView study →Reference 8RCTLutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration — the AREDS2 randomized clinical trial (includes the 80 mg vs 25 mg zinc sub-randomization)View study →.
- Topical: zinc oxide is used at 0.1–40% in creams and pastes; dosing is by product, not systemic intake.
Doses reflect ranges studied in research and are informational, not a personal recommendation.
Safety
General zinc cautions apply and are covered on the Zinc hub; the form-specific points are:
- Copper depletion is the dose-limiting harm of oral zinc. Sustained intake above the UL (notably the 80 mg AREDS dose) can cause copper deficiency (anemia, neutropenia, myelo-neuropathy) — which is exactly why the AREDS formula includes 2 mg copper 7Reference 7RCTA randomized, placebo-controlled clinical trial of high-dose vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss — AREDS report noView study →. Do not run high-dose oxide without matching copper.
- Absorption interactions: zinc competes with copper and iron for absorption, and separates in time from tetracycline/fluoroquinolone antibiotics (space ≥2 h). Poor fasting solubility does not exempt oxide from these interactions once dissolved.
- Topical zinc oxide is one of the best-tolerated dermatologic agents; contact allergy is rare. Sunscreen safety: human and review data show negligible dermal penetration of even nanoparticle ZnO, so systemic exposure from topical use is minimal 10,11Reference 10ReviewThe safety of nanosized particles in titanium dioxide- and zinc oxide-based sunscreens — reviewView study →Reference 11Human skin penetration and local effects of topical nano zinc oxide after occlusion and barrier impairment — human in-vivo validation studyView study →.
- Inhalation is a separate hazard unrelated to supplement use: inhaling zinc oxide fume (welding/galvanizing) causes metal-fume fever. Not relevant to oral or topical consumer products, but worth naming.
Pregnancy & lactation
Topical zinc oxide (barrier creams, sunscreen) is considered low-risk in pregnancy and lactation given its negligible absorption. High-dose oral zinc (the AREDS 80 mg regimen) is not a pregnancy indication and should not be self-selected. This form page does not add an oral-zinc pregnancy assessment beyond the hub; see Zinc for oral-zinc pregnancy detail.
Related compounds / cross-links
- Hub: Zinc — the full evidence base, intake references, and forms comparison table.
- Sibling forms: Zinc Citrate, Zinc Gluconate, Zinc Bisglycinate, Zinc Acetate, Zinc Picolinate.
- Interacts with: Copper (co-dose at high zinc intakes).
References
- Wegmüller, R., Tay, F., Zeder, C., Brnić, M., Hurrell, R. F. (2014). Zinc absorption by young adults from supplemental zinc citrate is comparable with that from zinc gluconate and higher than from zinc oxide — randomized crossover stable-isotope study. The Journal of Nutrition. https://pubmed.ncbi.nlm.nih.gov/24259556/
- Comparative Absorption and Bioavailability of Various Chemical Forms of Zinc in Humans: A Narrative Review (2024). Nutrients. https://pubmed.ncbi.nlm.nih.gov/39770891/
- Rosado, J. L., et al. (2005). Zinc absorption from zinc oxide, zinc sulfate, zinc oxide + EDTA, or sodium-zinc EDTA does not differ when added as fortificants to maize tortillas — stable-isotope study. The Journal of Nutrition. https://pubmed.ncbi.nlm.nih.gov/15867288/
- Bioavailability of zinc oxide added to corn tortilla is similar to that of zinc sulfate and is not affected by simultaneous addition of iron (2012) — randomized crossover isotope study. Food and Nutrition Bulletin. https://pubmed.ncbi.nlm.nih.gov/23424892/
- Cole, C., et al. (2010). Characterization of the UVA protection provided by avobenzone, zinc oxide, and titanium dioxide in broad-spectrum sunscreen products. American Journal of Clinical Dermatology. https://pubmed.ncbi.nlm.nih.gov/20806994/
- Pinnell, S. R., et al. (1999). Microfine zinc oxide (Z-cote) as a photostable UVA/UVB sunblock agent — comparative study. Journal of the American Academy of Dermatology. https://pubmed.ncbi.nlm.nih.gov/9922017/
- Age-Related Eye Disease Study Research Group (2001). A randomized, placebo-controlled clinical trial of high-dose vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss — AREDS report no. 8. Archives of Ophthalmology. https://pubmed.ncbi.nlm.nih.gov/11594942/
- AREDS2 Research Group (2013). Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration — the AREDS2 randomized clinical trial (includes the 80 mg vs 25 mg zinc sub-randomization). JAMA. https://pubmed.ncbi.nlm.nih.gov/23644932/
- Evans, J. R., Lawrenson, J. G. (2023). Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration — systematic review. Cochrane Database of Systematic Reviews. https://pubmed.ncbi.nlm.nih.gov/37702300/
- Nohynek, G. J., et al. (2009). The safety of nanosized particles in titanium dioxide- and zinc oxide-based sunscreens — review. Journal of the American Academy of Dermatology. https://pubmed.ncbi.nlm.nih.gov/19646780/
- Mohammed, Y. H., et al. (2016). Human skin penetration and local effects of topical nano zinc oxide after occlusion and barrier impairment — human in-vivo validation study. European Journal of Pharmaceutics and Biopharmaceutics. https://pubmed.ncbi.nlm.nih.gov/27131753/
- Efficacy of topical application of eosin compared with zinc oxide paste and corticosteroid cream for diaper dermatitis (1999) — randomized controlled trial. Dermatology. https://pubmed.ncbi.nlm.nih.gov/10640841/
- Skin benefits from continuous topical administration of a zinc oxide/petrolatum formulation by a novel disposable diaper (2001) — randomized controlled trial. JEADV. https://pubmed.ncbi.nlm.nih.gov/11720074/
- Lansdown, A. B., et al. (2007). Zinc in wound healing: theoretical, experimental, and clinical aspects — review. Wound Repair and Regeneration. https://pubmed.ncbi.nlm.nih.gov/17244314/